Lonza has aligned its business structure along the Healthcare Continuum and Microbial Control business. Stefan Stoffel has been appointed to a new role on the Executive Committee as chief operating officer, Lonza Pharma Biotech & Nutrition (LPBN), responsible for operations.   Incoming Group chief executive officer, Marc Funk said, “Our new structure will nurture synergies and increase operational efficiency, which will create customer benefits. More importantly, it will enable Lonza to de...